nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—G alpha (s) signalling events—CALCB—thyroid cancer	0.0545	0.0783	CbGpPWpGaD
Tofisopam—PDE2A—trachea—thyroid cancer	0.0462	0.152	CbGeAlD
Tofisopam—PDE10A—G alpha (s) signalling events—CALCB—thyroid cancer	0.0413	0.0593	CbGpPWpGaD
Tofisopam—PDE4A—DARPP-32 events—PRKAR1A—thyroid cancer	0.0398	0.0571	CbGpPWpGaD
Tofisopam—PDE10A—thyroid gland—thyroid cancer	0.0366	0.12	CbGeAlD
Tofisopam—PDE2A—thyroid gland—thyroid cancer	0.0366	0.12	CbGeAlD
Tofisopam—PDE10A—head—thyroid cancer	0.0324	0.107	CbGeAlD
Tofisopam—PDE2A—head—thyroid cancer	0.0324	0.107	CbGeAlD
Tofisopam—PDE2A—G alpha (s) signalling events—TSHR—thyroid cancer	0.0252	0.0362	CbGpPWpGaD
Tofisopam—PDE4A—thyroid gland—thyroid cancer	0.0252	0.0827	CbGeAlD
Tofisopam—PDE4A—G alpha (s) signalling events—CALCB—thyroid cancer	0.025	0.036	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—CALCB—thyroid cancer	0.0243	0.035	CbGpPWpGaD
Tofisopam—PDE2A—lymph node—thyroid cancer	0.0227	0.0747	CbGeAlD
Tofisopam—PDE10A—lymph node—thyroid cancer	0.0227	0.0747	CbGeAlD
Tofisopam—PDE3A—thyroid gland—thyroid cancer	0.0208	0.0684	CbGeAlD
Tofisopam—PDE10A—G alpha (s) signalling events—TSHR—thyroid cancer	0.0191	0.0275	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—CALCA—thyroid cancer	0.0189	0.0271	CbGpPWpGaD
Tofisopam—PDE4A—Opioid Signalling—PRKAR1A—thyroid cancer	0.016	0.023	CbGpPWpGaD
Tofisopam—PDE4A—lymph node—thyroid cancer	0.0156	0.0514	CbGeAlD
Tofisopam—PDE4A—G Protein Signaling Pathways—PRKAR1A—thyroid cancer	0.0143	0.0206	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—CALCA—thyroid cancer	0.0143	0.0206	CbGpPWpGaD
Tofisopam—PDE3A—lymph node—thyroid cancer	0.0129	0.0425	CbGeAlD
Tofisopam—PDE4A—G alpha (s) signalling events—TSHR—thyroid cancer	0.0116	0.0166	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—TSHR—thyroid cancer	0.0113	0.0162	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CALCB—thyroid cancer	0.0112	0.0161	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CALCB—thyroid cancer	0.0102	0.0146	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—CALCA—thyroid cancer	0.00867	0.0125	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CALCB—thyroid cancer	0.00847	0.0122	CbGpPWpGaD
Tofisopam—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00845	0.0121	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—CALCA—thyroid cancer	0.00843	0.0121	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—PRKAR1A—thyroid cancer	0.00806	0.0116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CALCB—thyroid cancer	0.00769	0.0111	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—PRKAR1A—thyroid cancer	0.00611	0.00877	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CALCB—thyroid cancer	0.006	0.00862	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TRIM33—thyroid cancer	0.00569	0.00817	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—IFNA2—thyroid cancer	0.00534	0.00767	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—TSHR—thyroid cancer	0.00518	0.00744	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CALCB—thyroid cancer	0.00513	0.00738	CbGpPWpGaD
Tofisopam—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.00506	0.00727	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CALCB—thyroid cancer	0.00499	0.00718	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—TSHR—thyroid cancer	0.0047	0.00675	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CALCB—thyroid cancer	0.00466	0.0067	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00462	0.00664	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CALCB—thyroid cancer	0.00454	0.00653	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CALCB—thyroid cancer	0.00453	0.00652	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TRIM33—thyroid cancer	0.00431	0.00619	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IFNA2—thyroid cancer	0.00404	0.00581	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—SST—thyroid cancer	0.00402	0.00578	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PTCH1—thyroid cancer	0.004	0.00574	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—TSHR—thyroid cancer	0.00392	0.00564	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—CALCA—thyroid cancer	0.00387	0.00557	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TCF7L1—thyroid cancer	0.00379	0.00545	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—SST—thyroid cancer	0.00366	0.00525	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PRKAR1A—thyroid cancer	0.0036	0.00517	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—TSHR—thyroid cancer	0.00356	0.00512	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—NRAS—thyroid cancer	0.00354	0.00509	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CALCA—thyroid cancer	0.00352	0.00506	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.0035	0.00504	CbGpPWpGaD
Tofisopam—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00333	0.00479	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—CDK1—thyroid cancer	0.00318	0.00458	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—SST—thyroid cancer	0.00305	0.00438	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—KRAS—thyroid cancer	0.00305	0.00438	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PTCH1—thyroid cancer	0.00303	0.00435	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.00294	0.00423	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—CALCA—thyroid cancer	0.00294	0.00422	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TCF7L1—thyroid cancer	0.00287	0.00413	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TSHR—thyroid cancer	0.00278	0.00399	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—SST—thyroid cancer	0.00277	0.00398	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CALCB—thyroid cancer	0.00275	0.00396	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PRKAR1A—thyroid cancer	0.00273	0.00393	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CALCB—thyroid cancer	0.00268	0.00385	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CALCA—thyroid cancer	0.00267	0.00383	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TRIM33—thyroid cancer	0.00261	0.00375	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MEN1—thyroid cancer	0.00261	0.00375	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—HRAS—thyroid cancer	0.00259	0.00373	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TRIM33—thyroid cancer	0.00254	0.00365	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—CDK1—thyroid cancer	0.00241	0.00347	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IFNA2—thyroid cancer	0.00238	0.00343	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—TSHR—thyroid cancer	0.00238	0.00341	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTCH1—thyroid cancer	0.00236	0.00339	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—TSHR—thyroid cancer	0.00231	0.00332	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—SST—thyroid cancer	0.00216	0.0031	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—TSHR—thyroid cancer	0.00216	0.0031	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00212	0.00305	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TSHR—thyroid cancer	0.0021	0.00302	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—TSHR—thyroid cancer	0.0021	0.00302	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CALCA—thyroid cancer	0.00208	0.00299	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PRKAR1A—thyroid cancer	0.00207	0.00297	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00207	0.00297	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00202	0.0029	CbGpPWpGaD
Tofisopam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00201	0.00288	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—NRAS—thyroid cancer	0.00199	0.00286	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MEN1—thyroid cancer	0.00198	0.00284	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDK1—thyroid cancer	0.00188	0.0027	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—SST—thyroid cancer	0.00185	0.00266	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PTCH1—thyroid cancer	0.00183	0.00264	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—SST—thyroid cancer	0.0018	0.00258	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTCH1—thyroid cancer	0.00179	0.00257	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PTCH1—thyroid cancer	0.00178	0.00257	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—CALCA—thyroid cancer	0.00178	0.00256	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TCF7L1—thyroid cancer	0.00174	0.0025	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—CALCA—thyroid cancer	0.00173	0.00249	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—KRAS—thyroid cancer	0.00171	0.00246	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TCF7L1—thyroid cancer	0.00169	0.00243	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—SST—thyroid cancer	0.00168	0.00241	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—SST—thyroid cancer	0.00164	0.00235	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00163	0.00235	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—SST—thyroid cancer	0.00163	0.00235	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CALCA—thyroid cancer	0.00162	0.00232	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CALCA—thyroid cancer	0.00158	0.00226	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CALCA—thyroid cancer	0.00157	0.00226	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TP53—thyroid cancer	0.00152	0.00219	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NRG1—thyroid cancer	0.00151	0.00217	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—NRAS—thyroid cancer	0.00151	0.00217	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—CDK1—thyroid cancer	0.00146	0.0021	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—HRAS—thyroid cancer	0.00146	0.00209	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDK1—thyroid cancer	0.00143	0.00205	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—CDK1—thyroid cancer	0.00142	0.00204	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TERT—thyroid cancer	0.00136	0.00195	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—KRAS—thyroid cancer	0.0013	0.00187	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HIF1A—thyroid cancer	0.0013	0.00186	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—AKT1—thyroid cancer	0.00129	0.00185	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TSHR—thyroid cancer	0.00127	0.00183	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PRKAR1A—thyroid cancer	0.00125	0.0018	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TSHR—thyroid cancer	0.00124	0.00178	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PRKAR1A—thyroid cancer	0.00122	0.00175	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MEN1—thyroid cancer	0.0012	0.00172	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MEN1—thyroid cancer	0.00117	0.00168	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TP53—thyroid cancer	0.00115	0.00166	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NRG1—thyroid cancer	0.00114	0.00164	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—NRAS—thyroid cancer	0.00114	0.00164	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—HRAS—thyroid cancer	0.0011	0.00159	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTCH1—thyroid cancer	0.00108	0.00156	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—BRAF—thyroid cancer	0.00107	0.00154	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTCH1—thyroid cancer	0.00105	0.00152	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TERT—thyroid cancer	0.00103	0.00148	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SST—thyroid cancer	0.000991	0.00142	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—KRAS—thyroid cancer	0.000983	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HIF1A—thyroid cancer	0.000983	0.00141	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—AKT1—thyroid cancer	0.000974	0.0014	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SST—thyroid cancer	0.000964	0.00139	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CALCA—thyroid cancer	0.000954	0.00137	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CALCA—thyroid cancer	0.000928	0.00133	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—NRAS—thyroid cancer	0.000889	0.00128	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000868	0.00125	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—NRAS—thyroid cancer	0.000866	0.00124	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDK1—thyroid cancer	0.000864	0.00124	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDK1—thyroid cancer	0.00084	0.00121	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—HRAS—thyroid cancer	0.000836	0.0012	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—BRAF—thyroid cancer	0.000814	0.00117	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—AKT1—thyroid cancer	0.000813	0.00117	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCND1—thyroid cancer	0.000784	0.00113	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—KRAS—thyroid cancer	0.000765	0.0011	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTEN—thyroid cancer	0.000756	0.00109	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—KRAS—thyroid cancer	0.000745	0.00107	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—AKT1—thyroid cancer	0.000738	0.00106	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NRG1—thyroid cancer	0.000693	0.000996	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TP53—thyroid cancer	0.00068	0.000977	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NRAS—thyroid cancer	0.000675	0.00097	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NRG1—thyroid cancer	0.000675	0.000969	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—HRAS—thyroid cancer	0.00065	0.000935	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MINPP1—thyroid cancer	0.000638	0.000917	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—HRAS—thyroid cancer	0.000633	0.00091	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TERT—thyroid cancer	0.000623	0.000895	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—AKT1—thyroid cancer	0.000616	0.000885	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TERT—thyroid cancer	0.000606	0.00087	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HIF1A—thyroid cancer	0.000595	0.000856	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCND1—thyroid cancer	0.000594	0.000853	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KRAS—thyroid cancer	0.000581	0.000835	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HIF1A—thyroid cancer	0.000579	0.000832	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—AKT1—thyroid cancer	0.000574	0.000825	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTEN—thyroid cancer	0.000573	0.000824	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—AKT1—thyroid cancer	0.000559	0.000804	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NDUFA13—thyroid cancer	0.000542	0.000779	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—NRAS—thyroid cancer	0.000525	0.000754	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—thyroid cancer	0.000516	0.000742	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NRAS—thyroid cancer	0.000511	0.000735	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—NRAS—thyroid cancer	0.00051	0.000733	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CHST14—thyroid cancer	0.00051	0.000733	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HRAS—thyroid cancer	0.000494	0.000709	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—BRAF—thyroid cancer	0.000493	0.000709	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—BRAF—thyroid cancer	0.00048	0.000689	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—KRAS—thyroid cancer	0.000451	0.000649	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KRAS—thyroid cancer	0.00044	0.000633	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—KRAS—thyroid cancer	0.000439	0.000631	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—AKT1—thyroid cancer	0.000436	0.000626	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—HPGD—thyroid cancer	0.000411	0.000591	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—thyroid cancer	0.000391	0.000562	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—HRAS—thyroid cancer	0.000384	0.000551	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HRAS—thyroid cancer	0.000374	0.000538	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—HRAS—thyroid cancer	0.000373	0.000536	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—AKT1—thyroid cancer	0.000373	0.000536	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—AKT1—thyroid cancer	0.000363	0.000522	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCND1—thyroid cancer	0.00036	0.000517	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCND1—thyroid cancer	0.00035	0.000503	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTEN—thyroid cancer	0.000347	0.000499	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—AKT1—thyroid cancer	0.000339	0.000487	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTEN—thyroid cancer	0.000338	0.000486	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—AKT1—thyroid cancer	0.00033	0.000475	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—AKT1—thyroid cancer	0.00033	0.000474	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NRAS—thyroid cancer	0.00031	0.000445	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NRAS—thyroid cancer	0.000301	0.000433	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KRAS—thyroid cancer	0.000267	0.000383	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KRAS—thyroid cancer	0.000259	0.000373	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—thyroid cancer	0.000237	0.000341	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—TPR—thyroid cancer	0.000236	0.000339	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	0.000232	0.000334	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—thyroid cancer	0.000231	0.000331	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HRAS—thyroid cancer	0.000227	0.000326	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HRAS—thyroid cancer	0.000221	0.000317	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKT1—thyroid cancer	0.0002	0.000288	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKT1—thyroid cancer	0.000195	0.00028	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A5—thyroid cancer	0.000177	0.000254	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—RXRA—thyroid cancer	0.000148	0.000213	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPARG—thyroid cancer	9.38e-05	0.000135	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—thyroid cancer	7.38e-05	0.000106	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTEN—thyroid cancer	6.43e-05	9.24e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AKT1—thyroid cancer	3.71e-05	5.33e-05	CbGpPWpGaD
